Revision history of "Preclinical continuing development of a manuscript CD3CD123 bispecific Tcell engager using crossover dualvariable website CODV formatting with regard to severe myeloid leukemia AML remedy"
From EECH Central
Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.